JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2004) 183, 115-120       DOI: 10.1677/joe.1.05830
© 2004 Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhattacharyya, S.
Right arrow Articles by O’Rahilly, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhattacharyya, S.
Right arrow Articles by O’Rahilly, S.

Studies of the neuromedin U-2 receptor gene in human obesity: evidence for the existence of two ancestral forms of the receptor

Sumit Bhattacharyya1,2, Jian’an Luan3, I Sadaf Farooqi1,2, Julia Keogh1,2, Carl Montague4, John Brennand4, Lynn Jorde5, Nicholas J Wareham3 and Stephen O’Rahilly1,2

1 University of Cambridge, Department of Medicine, Box 232, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, UK
2 University of Cambridge, Department of Clinical Biochemistry, Box 232, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, UK
3 University of Cambridge, Public Health and Primary Care, Box 232, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, UK
4 CVGI Discovery, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, UK
5 Department of Human Genetics, University of Utah Health Sciences Center, Salt Lake City, Utah, USA

(Requests for offprints should be addressed to S O’Rahilly; Email: sorahill{at}hgmp.mrc.ac.uk)

Central administration of neuromedin U (NMU) suppresses food intake acting through the NMU-2 receptor (NMU2R), which is expressed in the hypothalamus. We screened the NMU2R gene in 96 patients with severe early-onset obesity. A common variant haplotype was found (f-0.21). This common variant haplotype was unusual in nature, consisting of four non-contiguous missense changes in complete linkage disequilibrium, and across two separate exons. The variant haplotype resulted in four amino acid substitutions (S295T/F312L/P380L/ M385 V) and was present in several other Europid populations and in subjects of South Asian, East Asian and African American origin, but not in eleven African Pygmies. This variant haplotype was not associated with obesity or related traits in 500 subjects from a prospective population-based cohort.

In summary, we have identified two markedly different isoforms of the NMU-2 receptor, presumably arising through an ancient and complex mutational event; no genetic associations between this haplotype and obesity-related traits were, however, discerned. Further investigation of the pharmacogenomic consequences of NMU2R variation in humans is warranted.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
I. Hainerova, S. S. Torekov, J. Ek, M. Finkova, K. Borch-Johnsen, T. Jorgensen, O. D. Madsen, J. Lebl, T. Hansen, and O. Pedersen
Association between Neuromedin U Gene Variants and Overweight and Obesity
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5057 - 5063.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Endocrinology.